Amsterdam UMC researchers Rubina Baglio and Michiel Pegtel together with Daniël Warmerdam from the CRISPR Platform have received a grant from the Cancer Center Amsterdam to further develop a new delivery method for CRISPR/Cas in cells and tissues for the potential application in the treatment of cancer.
In accordance with the current EU data protection laws, please take a minute to review our privacy rules, which describe how we use the data generated during your visit and the options available to you.